METHODS:It was a randomized single-blind study. A total of 39 AD patients were assigned into huperzine A group(Harborin,cholinesterase inhibitor),Harborin plu s aspirin group and placebo group.

• 方法:采用随机单盲法,分别将39例AD患者分为石杉碱甲组、石杉碱甲加肠溶阿司匹林治疗组和安慰剂组。